Anchiano Therapeutics Competitors and Similar CompaniesClear all
Anchiano Therapeutics's competitors and similar companies include Kymab.
 Anchiano Therapeutics Anchiano Therapeutics is a clinical-stage biotechnology company that develops gene therapies to treat early-stage bladder cancer. |  Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. | |
Founding Date | Founding Date 2004 | Founding Date 2009 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations Cambridge, GB HQ |
Employees | Employees 1912% increase | Employees 407% decrease |
Funding | ||
Total funding raised | Total funding raised $ 29m | Total funding raised $ 220.4m |
For sources of this data, please see the company profile
View Company Profiles
Kymab
HQ
Cambridge, GB
Employees
40↓ 7% decrease
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
View company